ERBB2 and breast cancer: This study was designed to evaluate the possibility of automatically extracting the status of the 3 main breast cancer biomarkers (ER, PR, and HER2) from the contents of pathology reports written in two different languages, and coming from 82 different providers, using conventional machine learning models.